Federal Supply Schedule 36F79719D0229
Award Date 8/15/19
Last Date to Order 7/14/25
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- Stemline Therapeutics, Inc. has been awarded a Multiple Award Federal Supply Schedule contract under General Services Administration schedule 61-IB (Pharmaceuticals and Drugs) to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12, a civilian federal agency within the Department of Veterans Affairs. The contract was awarded on July 15, 2025, with a ceiling value of $38,007,730 and an ultimate completion date of July 14, 2030,...
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
- The Federal Supply Schedule contract is a multiple award, indefinite delivery vehicle awarded to Verastem, Inc. by the Department of Veterans Affairs for DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. The contract has a ceiling value of $25,000.00 and a period of performance through January 31, 2026. As a Federal Supply Schedule contract, it provides government agencies with access to commercial products and services at pre-negotiated prices, terms, and conditions. The contract...
- The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
- This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
- STI Pharma LLC was awarded a multiple-award Federal Supply Schedule contract under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB) on August 15, 2017, with a ceiling value of $225,000.00. The contract was funded by the Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs, and did not utilize set-aside provisions. The contract's scope encompasses the supply of drugs, pharmaceuticals, and hematology-related...
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs, to Sola Pharmaceuticals, LLC. The contract has a period of performance from June 15, 2023 through June 14, 2028, with a ceiling value of $1,500,000.00. The contract is for the provision of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under Federal Supply Schedule 65 I B. As a Federal Supply Schedule...
- This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to G1 Therapeutics, Inc. for the provision of pharmaceutical and drug products. The contract has a ceiling value of $2,250,000.00 and a period of performance through July 14, 2026. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and allows for the delivery of a broad range of drug and hematology-related products to the VA and its related healthcare...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Springworks Therapeutics, Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through April 14, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows government agencies to procure these...
- The Federal Supply Schedule (FSS) contract award is for DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS (65 I B) on behalf of the Veterans Integrated Service Network 12, a civilian federal agency. The $51,322,640.00 ceiling value contract was awarded on July 1, 2020 to Assertio Therapeutics Inc., a for-profit manufacturer, with a period of performance through October 14, 2025. This multiple award contract provides federal agencies access to a variety of pharmaceutical products and...